| Relevance | RGD ID | Symbol | Name | LOD | P Value | Trait | Sub Trait | Chr | Start | Stop | Species | Annotations | Match | Type | 1000 | 1576345 | LVC1_H | Left ventricular contractility QTL 1 (human) | 3.93 | Left ventricular contractility | 11 | 16817071 | 70403343 | Human | n/a | region | qtl | 1000 | 1559104 | SCL15_H | Serum cholesterol level QTL 15 (human) | 2.6 | .06 | Lipid level | hyperlipidemia susceptibility | 11 | 17086204 | 79965640 | Human | n/a | region | qtl | 1000 | 1559113 | SCL31_H | Serum cholesterol level QTL 31 (human) | 3.72 | Lipid level | LDL cholesterol | 11 | 28913978 | 70403233 | Human | n/a | region | qtl | 1000 | 1559107 | SCL32_H | Serum cholesterol level QTL 32 (human) | 3.27 | Lipid level | LDL cholesterol | 11 | 28913978 | 70403233 | Human | n/a | region | qtl | 1000 | 1298492 | BP31_H | Blood pressure QTL 31 (human) | 2.07 | Blood pressure | systolic | 11 | 34640077 | 123626865 | Human | n/a | region | qtl | 1000 | 1357289 | AASTH31_H | Allergic/atopic asthma related QTL 31 (human) | 2 | Reversible airflow obstruction | 11 | 40974301 | 81574509 | Human | n/a | region | qtl | 1000 | 2292783 | MYI29_H | Myocardial infarction susceptibility QTL 29 (human) | Myocardial infarction susceptibility | early-onset | 11 | 43205915 | 69205915 | Human | n/a | region | qtl | 1000 | 1357297 | AASTH21_H | Allergic/atopic asthma related QTL 21 (human) | 2 | .002 | Reversible airflow obstruction | post-bronchodilator FEV1 | 11 | 45496349 | 71496349 | Human | n/a | region | qtl | 1000 | 1643410 | BW281_H | Body Weight QTL 281 (human) | 2.03 | .001 | Body weight | 11 | 45496349 | 71496349 | Human | n/a | region | qtl | 1000 | 2292918 | PRSTS142_H | Prostate tumor susceptibility QTL 142 (human) | 6.12 | .000015 | Prostate tumor susceptibility | 11 | 54893394 | 80893394 | Human | n/a | region | qtl | 1000 | 2292942 | PRSTS195_H | Prostate tumor susceptibility QTL 195 (human) | 1.28 | Prostate tumor susceptibility | 11 | 54893394 | 80893394 | Human | n/a | region | qtl | 1000 | 2293009 | PRSTS194_H | Prostate tumor susceptibility QTL 194 (human) | 1.57 | Prostate tumor susceptibility | 11 | 54893394 | 80893394 | Human | n/a | region | qtl | 1000 | 2316064 | GLUCO210_H | Glucose level QTL 210 (human) | .027 | Glucose level | 11 | 54893394 | 80893394 | Human | n/a | region | qtl | 1000 | 2289174 | SADIPOQ7_H | Serum adiponectin level QTL 7 (human) | 4.2 | Hormone level | adiponectin level | 11 | 58496495 | 120828264 | Human | n/a | region | qtl | 1000 | 2289508 | BW452_H | Body weight QTL 452 (human) | 2.36 | Body fat amount | abdominal | 11 | 59721888 | 73505325 | Human | n/a | region | qtl | 1000 | 2289505 | BW447_H | Body weight QTL 447 (human) | 2.94 | Body morphometry | waist to hip ratio | 11 | 59721888 | 73505325 | Human | n/a | region | qtl | 1000 | 2289200 | BW356_H | Body weight QTL 356 (human) | .0163 | Body fat amount | percent fat | 11 | 60505228 | 86505228 | Human | n/a | region | qtl | 1000 | 1643405 | BMD9_H | Bone mineral density QTL 9 (human) | 2.64 | .0002 | Bone mineral density | 11 | 60505228 | 86505228 | Human | n/a | region | qtl | 1000 | 1643360 | BW339_H | Body weight QTL 339 (human) | 2 | Body fat amount | percent body fat | 11 | 60505228 | 86505228 | Human | n/a | region | qtl | 1000 | 1643371 | BW329_H | Body weight QTL 329 (human) | 2.64 | .0002 | Body fat amount | 11 | 60505228 | 86505228 | Human | n/a | region | qtl | 1000 | 2292771 | PRSTS33_H | Prostate tumor susceptibility QTL 33 (human) | Prostate tumor susceptibility | early onset | 11 | 60505228 | 86505228 | Human | n/a | region | qtl | 1000 | 2300235 | PRSTS358_H | Prostate tumor susceptibility QTL 358 (human) | .018 | Prostate tumor susceptibility | 11 | 60505228 | 86505228 | Human | n/a | region | qtl | |
© Bioinformatics Program, HMGC at the Medical College of Wisconsin
RGD is funded by grant HL64541 from the National Heart, Lung, and Blood Institute on behalf of the NIH.